CONNAUGHT TECHNOLOGY CORP has a total of 12 patent applications. Its first patent ever was published in 1992. It filed its patents most often in EPO (European Patent Office), Canada and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are VIROGENETICS CORP, DNAVEC CORP and GENETIC THERAPY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | Canada | 2 | |
#3 | United States | 2 | |
#4 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Paoletti Enzo | 9 |
#2 | Tartaglia James | 7 |
#3 | Cox William I | 7 |
#4 | Pincus Steven E | 4 |
#5 | Taylor Jill | 4 |
#6 | Alexander Jeannine | 3 |
#7 | Perkus Marion E | 3 |
#8 | Johnson Gerard P | 3 |
#9 | Gettig Russell Robert | 3 |
#10 | Norton Elizabeth K | 3 |
Publication | Filing date | Title |
---|---|---|
US7255862B1 | ALVAC/FIV constructs | |
CA2558659A1 | Genetically engineered canary poxvirus-based vaccine strain | |
CA2621088A1 | Genetically engineered fowlpox-based vaccine strain | |
EP1367128A1 | Genetically engineered vaccine strain |